$0.703
+0.06
(+9.62%)▲
Insights on Akso Health Group
Revenue is down for the last 4 quarters, 6311.07B → 894.76K (in $), with an average decrease of 74.1% per quarter
Netprofit is down for the last 4 quarters, 14.71M → -3.06M (in $), with an average decrease of 168.7% per quarter
12.86%
Downside
Day's Volatility :34.41%
Upside
24.73%
64.21%
Downside
52 Weeks Volatility :91.36%
Upside
75.86%
Period | Akso Health Group | Sector (Financials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -47.14% | 7.2% | 0.0% |
6 Months | -37.17% | 21.4% | 0.0% |
1 Year | 107.68% | 29.8% | 0.0% |
3 Years | -65.2% | 13.5% | -20.0% |
Market Capitalization | 94.1M |
Book Value | $0.23 |
Earnings Per Share (EPS) | -0.81 |
Profit Margin | -253.73% |
Operating Margin TTM | -259.16% |
Return On Assets TTM | -54.13% |
Return On Equity TTM | -233.19% |
Revenue TTM | 2.2M |
Revenue Per Share TTM | 0.1 |
Quarterly Revenue Growth YOY | -92.5% |
Gross Profit TTM | 1.3M |
EBITDA | -14.2M |
Diluted Eps TTM | -0.81 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 107.3M | ↑ 367.96% |
Net Income | 65.5M | ↑ 664.01% |
Net Profit Margin | 61.05% | ↑ 23.66% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 61.3M | ↓ 42.82% |
Net Income | 5.5M | ↓ 91.55% |
Net Profit Margin | 9.02% | ↓ 52.03% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 11.4M | ↓ 81.36% |
Net Income | -71.2M | ↓ 1386.89% |
Net Profit Margin | -622.63% | ↓ 631.65% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.8M | ↓ 84.65% |
Net Income | -31.6M | ↓ 55.68% |
Net Profit Margin | -1.8K% | ↓ 1175.29% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 6.3M | ↑ 259.62% |
Net Income | -16.8M | ↓ 46.6% |
Net Profit Margin | -266.99% | ↑ 1530.93% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 6.3M | ↑ 0.0% |
Net Income | -16.8M | ↑ 0.0% |
Net Profit Margin | -266.99% | ↑ 0.0% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 6.3T | - |
Net Income | 14.7M | - |
Net Profit Margin | 0.0% | - |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 11.9M | ↓ 100.0% |
Net Income | 810.3K | ↓ 94.49% |
Net Profit Margin | 6.83% | ↑ 6.83% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.4M | ↓ 88.61% |
Net Income | -2.2M | ↓ 372.63% |
Net Profit Margin | -163.4% | ↓ 170.23% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 894.8K | ↓ 33.82% |
Net Income | -3.1M | ↑ 38.88% |
Net Profit Margin | -342.89% | ↓ 179.49% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 163.9M | ↑ 477.44% |
Total Liabilities | 23.8M | ↑ 388.89% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 173.3M | ↑ 5.71% |
Total Liabilities | 46.8M | ↑ 96.05% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 78.4M | ↓ 54.76% |
Total Liabilities | 30.3M | ↓ 35.23% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 31.7M | ↓ 59.58% |
Total Liabilities | 14.4M | ↓ 52.4% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 50.7M | ↑ 59.95% |
Total Liabilities | 38.4M | ↑ 166.37% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 50.7M | ↑ 0.0% |
Total Liabilities | 38.4M | ↑ 0.0% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 50.7M | - |
Total Liabilities | 38.4M | - |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 20.5M | ↓ 59.63% |
Total Liabilities | 11.6M | ↓ 69.73% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 20.5M | ↑ 0.0% |
Total Liabilities | 11.6M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 20.5M | ↑ 0.0% |
Total Liabilities | 11.6M | ↑ 0.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 16.9M | ↓ 17.5% |
Total Liabilities | 11.5M | ↓ 0.62% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 16.9M | ↑ 0.0% |
Total Liabilities | 11.5M | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 87.7M | ↑ 971.13% |
Investing Cash Flow | -27.6M | - |
Financing Cash Flow | 47.5M | ↑ 1007.95% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -1.7M | ↓ 101.97% |
Investing Cash Flow | -68.1M | ↑ 146.55% |
Financing Cash Flow | -29.4K | ↓ 100.06% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -55.9M | ↑ 3127.23% |
Investing Cash Flow | 12.8M | ↓ 118.76% |
Financing Cash Flow | -4.0M | ↑ 13397.63% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 10.1M | ↓ 118.0% |
Investing Cash Flow | -662.0 | ↓ 100.01% |
Financing Cash Flow | -9.0M | ↑ 127.91% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -8.6M | ↓ 185.78% |
Investing Cash Flow | -20.0M | ↑ 3015588.82% |
Financing Cash Flow | 34.8M | ↓ 484.87% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -8.6M | ↑ 0.0% |
Investing Cash Flow | 18.5M | ↓ 192.52% |
Financing Cash Flow | 34.8M | ↑ 0.0% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -667.1K | ↓ 100.89% |
Investing Cash Flow | 10.0M | - |
Financing Cash Flow | -13.8M | ↓ 129.28% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -667.1K | ↑ 0.0% |
Investing Cash Flow | 10.0M | ↑ 0.0% |
Financing Cash Flow | -13.8M | ↑ 0.0% |
Sell
Neutral
Buy
Akso Health Group is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Akso Health Group | -28.98% | -37.17% | 107.68% | -65.2% | -65.2% |
Cardinal Health, Inc. | -6.53% | -5.87% | 15.8% | 76.08% | 115.48% |
Cencora Inc | -6.4% | 13.36% | 24.16% | 87.24% | 92.56% |
Mckesson Corporation | 8.81% | 24.63% | 41.89% | 186.14% | 346.61% |
Henry Schein, Inc. | 6.62% | 8.73% | -2.55% | -5.99% | 8.92% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Akso Health Group | NA | NA | NA | 0.0 | -2.33 | -0.54 | NA | 0.23 |
Cardinal Health, Inc. | 43.67 | 43.67 | 0.31 | 7.36 | 0.0 | 0.03 | 0.02 | -13.38 |
Cencora Inc | 23.39 | 23.39 | 1.58 | 11.93 | 2.34 | 0.03 | 0.01 | 3.39 |
Mckesson Corporation | 24.81 | 24.81 | 4.96 | 27.59 | 0.0 | 0.04 | 0.0 | -15.16 |
Henry Schein, Inc. | 25.03 | 25.03 | 1.65 | 5.08 | 0.08 | 0.04 | NA | 28.02 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Akso Health Group | NA | $94.1M | -65.2% | NA | -253.73% |
Cardinal Health, Inc. | Hold | $24.0B | 115.48% | 43.67 | 0.25% |
Cencora Inc | Buy | $38.5B | 92.56% | 23.39 | 0.66% |
Mckesson Corporation | Buy | $72.2B | 346.61% | 24.81 | 0.97% |
Henry Schein, Inc. | Hold | $9.5B | 8.92% | 25.03 | 3.12% |
Renaissance Technologies Corp
Two Sigma Investments LLC
Geode Capital Management, LLC
Rhumbline Advisers
Millennium Management LLC
In the quarter ending December,2018. Akso Health Group has declared dividend of $0.81
Read More和信电子商务有限公司 is a company based out of china.
Organization | Akso Health Group |
Employees | 12 |
CEO | Ms. Yilin Wang |
Industry | Services |
Destination Xl Group Inc
$0.70
+9.62%
Barrett Business Services Inc
$0.70
+9.62%
Grupo Televisa, S.a.b.
$0.70
+9.62%
Stitch Fix, Inc. (class A Shares)
$0.70
+9.62%
E. W. Scripps Company, Class A Shares
$0.70
+9.62%
Jack In The Box Inc.
$0.70
+9.62%
Qurate Retail Inc
$0.70
+9.62%
One Group Hospitality Inc/th
$0.70
+9.62%
Iheartmedia
$0.70
+9.62%